Triple Positive Metastatic Breast Cancer: Clinical Insights from a US Oncologists Survey


#30863

30pages

Assessment Group

$ 2999

In Stock

 

Primary research that presents a patient specific case scenario unfolding throughout the report, to 174 high-prescribing oncologists on Triple Positive Metastatic Breast Cancer for their open responses on specific clinical decisions. 

 

Patient progression reveals:

 

  • Decisions in treatment throughout patient stages
  • Factors influencing their decisions
  • Barriers to optimal care
  • Confidence in treatment.

 

Data has been synthesized to show the highest reported responses, “other” responses, and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Triple Positive Metastatic Breast Cancer. 

 

Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer. 

 

This report allows you to:

 

  • Understand what occurs with actual patients
  • Access the most up-to-date prescribing trends
  • Gain actionable data for developing and improving your market strategies
  • Pinpoint needs of your target audience
  • Focus resources to maximize the effectiveness of your budget
  • Understand where your product fits
  • Understand where your competitor’s product fits
  • Design messages to advance brand performance

 

Patient specific case scenario that unfold throughout the report, presented to 174 high-prescribing oncologists on Triple Positive Metastatic Breast Cancer for their open responses on clinical decisions. Patient progression reveals decisions in treatment throughout patient stages, factors influencing their decisions, barriers to optimal care, and confidence in treatment.

Table of Contents

 

Executive Summary

 

Chapter 1: Introduction

Table 1. Treatment Options in Triple Positive Metastatic Breast Cancer

 

Chapter 2: Respondent Demographics

Table 2. Eligibility Criteria for Survey Participation

Figure 2.1 Gender of Survey Respondents

Figure 2.2 Years since Medical School Graduation

Figure 2.3 Practice Settings

Figure 2.4 Practices in NCI Cancer Centers

Figure 2.5 Geographic Settings

Figure 2.6 Survey Respondents by State’s Breast Cancer Mortality

Figure 2.7 Number of Physicians in Practice Groups

Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen

 

Chapter 3: Optimizing Treatment for Triple Positive Metastatic Breast Cancer

Next step for patient with triple positive metastatic breast cancer

Figure 3. 1

Treatment of progressive disease, triple positive metastatic breast cancer

Figure 3.2

Single chemotherapy choices for progressive triple positive metastatic breast cancer

Figure 3.3

Combination chemotherapy, progressive triple positive metastatic breast cancer

Figure 3.4

Factors influencing treatment of progressive triple positive metastatic breast cancer

Figure 3.5

Treatment regimen for continued progression of triple positive metastatic breast cancer

Figure 3.6

Decisions regarding the use of lapatinib in progressive triple positive metastatic breast cancer

Figure 3.7

Management of progressive disease, triple positive metastatic breast cancer

Figure 3.8

 

Chapter 4: Summary

Appendix A: Survey Instrument

NA

NA